1. Zhou, Lijie, Song, Zhengshuai, Hu, Junyi, Yang, Xiong, Chen, Ke. 2021. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. In Theranostics, 11, 841-860. doi:10.7150/thno.49384. https://pubmed.ncbi.nlm.nih.gov/33391508/
2. Zhou, Bing, Luo, Yunchen, Bi, Hanqi, Hu, Cheng, Lu, Yan. 2024. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11. In Cell metabolism, 36, 2228-2244.e7. doi:10.1016/j.cmet.2024.07.014. https://pubmed.ncbi.nlm.nih.gov/39146936/
3. Jia, Zhihao, Chen, Xiyue, Chen, Jingjuan, Yue, Feng, Kuang, Shihuan. . ACSS3 in brown fat drives propionate catabolism and its deficiency leads to autophagy and systemic metabolic dysfunction. In Clinical and translational medicine, 12, e665. doi:10.1002/ctm2.665. https://pubmed.ncbi.nlm.nih.gov/35184387/
4. Chang, Wei-Chun, Cheng, Wei-Chung, Cheng, Bi-Hua, Hung, Yao-Ching, Ma, Wen-Lung. 2018. Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. In Cancer medicine, 7, 1240-1252. doi:10.1002/cam4.1295. https://pubmed.ncbi.nlm.nih.gov/29493120/
5. Jo, Jinyeon, Song, Youngkyu, Yoon, Dankyu, Lee, Chung Gun, Won, Sungho. 2022. Genome-wide assessment reveals a significant association between ACSS3 and physical activity. In Genes, brain, and behavior, 22, e12834. doi:10.1111/gbb.12834. https://pubmed.ncbi.nlm.nih.gov/36510703/
6. Zhang, Jing, Wang, Xiuhong, Wang, Jingyi, Wang, Bei, Hu, Wenquan. 2025. ACSS3 promotes the tumorigenesis of non-small cell lung cancer via suppressing p53-mediated ferroptosis. In Experimental cell research, 446, 114438. doi:10.1016/j.yexcr.2025.114438. https://pubmed.ncbi.nlm.nih.gov/39961466/
智鼠故事 
